Adimmune Market Cap

Adimmune has a market cap or net worth of 9.27 billion as of January 17, 2025. Its market cap has decreased by -32.82% in one year.

Market Cap

9.27B

Enterprise Value

10.40B

Revenue

1.57B

Ranking

n/a

PE Ratio

n/a

Stock Price

22.00

Market Cap Chart

Since September 29, 2010, Adimmune's market cap has decreased from 11.10B to 9.27B, a decrease of -16.44%. That is a compound annual growth rate of -1.25%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2025	9.17B	8.21%
Dec 31, 2024	8.47B	-39.37%
Dec 29, 2023	13.97B	-7.97%
Dec 30, 2022	15.18B	-20.83%
Dec 30, 2021	19.18B	-20.41%
Dec 31, 2020	24.10B	162.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	235.68B
Caliway Biopharmaceuticals	98.05B
Bora Pharmaceuticals Co., LTD.	80.81B
Lotus Pharmaceutical	69.14B
Lumosa Therapeutics	40.11B
Oneness Biotech	37.34B
Polaris Group	32.38B
Center Laboratories	29.18B

Market Cap Rankings